perinatal pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pregnant or postpartum women aged 22–40 years; 2. Willing to comply with all study-related requirements; 3. Willing and able to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. Severe cognitive impairment; 2. Current or previous diagnosis of epilepsy, dementia, migraine, or any other neurological condition that could interfere with mixed-reality use or pose adverse effects; 3. Presence of nausea or dizziness; 4. Sensitivity to luminous screens; 5. Absence of stereoscopic vision or severe hearing impairment; 6. Injury to the eyes, face, or neck that would prevent comfortable wear of the headset; 7. GAD-7 score = 10 or PHQ-9 score = 10; 8. Prior use of VR or MR devices for pain management; 9. Participation in any other clinical study within the past 2 months; 10. Current employment, or having a first-degree relative employed, by a digital-health or pharmaceutical company that provides acute or chronic pain therapies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in pain intensity before and after MR therapy (VAS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Emotional changes before and after MR therapy ; | — |
Countries
China
Contacts
Shanghai Tenth People's Hospital